SQSTM1 and metabolic dysfunction-associated steatotic liver disease: Another study reported that the suppressed expressions of cathepsin family enzymes increased p62/SQSTM1 level in patients with NAFLD with autophagic dysfunction and hepatic inflammasome (Table 3) [437].